The clinical safety and efficacy of conventional transcatheter arterial chemoembolization and drug-eluting beads-transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: A meta-analysis-Reference-Cited by-同舟云学术

The clinical safety and efficacy of conventional transcatheter arterial chemoembolization and drug-eluting beads-transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: A meta-analysis

Published:2019-10-31 Issue:5 Volume:13 Page:374-381
ISSN:1881-7815
Container-title:BioScience Trends
language:en
Short-container-title:BST

Author:

Han Tao¹,Yang Xiaodan¹,Zhang Yue¹,Li Gao²,Liu Lu¹,Chen Tingsong³,Zheng Zhendong¹

Affiliation:

1. Department of Oncology, Cancer Center, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.

2. Department of Clinical Pharmacy, Shenyang Pharmaceutical University, Shenyang, China.

3. Department of Invasive Technology, The Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine,Health (social science)

Link

https://www.jstage.jst.go.jp/article/bst/13/5/13_2019.01153/_pdf

Reference39 articles.

1. 1. Boyle DA. Hepatocellular Carcinoma: Implications for Asia-Pacific oncology nurses. Asia Pac J Oncol Nurs. 2017; 4:98-103.

2. 2. Xie H, Yu H, Tian S, Yang X, Wang X, Yang Z, Wang H, Guo Z. What is the best combination treatment with transarterial chemoembolization of unresectable hepatocellular carcinoma? A systematic review and network meta-analysis. Oncotarget. 2017; 8:100508-100523.

3. 3. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015; 65:87-108.

4. 4. Kaneko R, Nakazaki N, Omori R, Yano Y, Ogawa M, Sato Y. The effect of new therapeutic and diagnostic agents on the prognosis of hepatocellular carcinoma in Japan - An analysis of data from the Kanagawa Cancer Registry. Asian Pac J Cancer Prev. 2017; 18:2471-2476.

5. 5. Pascual S, Herrera I, Irurzun J. New advances in hepatocellular carcinoma. World J Hepatol. 2016; 8:421-438.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pingyangmycin-loaded drug-eluting beads transarterial embolisation for giant cavernous haemangioma of the liver: A case report;Heliyon;2024-08

2. Efficacy and Safety of Drug-Loaded Microsphere-Based Transcatheter Arterial Chemoembolization for the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus;Journal of Biomedical Nanotechnology;2024-03-01

3. Retrospective analysis of the efficacy and survival associated with cTACE and DEB-TACE in the palliative treatment of hepatocellular carcinoma: experience of a tertiary care hospital in southern Brazil;Radiologia Brasileira;2024

4. Efficacy and Safety of TACE Combined with TIPS in the Treatment of Hepatocellular Carcinoma Complicated with Portal Hypertension: A Meta-Analysis;Advances in Clinical Medicine;2024

5. Analysis of the Efficacy and Safety of Palonosetron Hydrochloride in Preventing Nausea And Vomiting After TACE: A Retrospective Analysis;Current Radiopharmaceuticals;2023-11-13